Crossmark

Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab

Crossref DOI link: https://doi.org/10.1007/s00262-018-2182-4

Published Online: 2018-06-09

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Putzu, Carlo

Cortinovis, Diego Luigi

Colonese, Francesca

Canova, Stefania

Carru, Ciriaco

Zinellu, Angelo

Paliogiannis, Panagiotis https://orcid.org/0000-0001-5485-6056
License Information

Text and Data Mining valid from 2018-06-09
More Information

Article History

Received: 6 February 2018

Accepted: 2 June 2018

First Online: 9 June 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The study was performed in accordance with the Declaration of Helsinki.

: All patients signed an informed consent for the treatments performed and for the anonymous use of their demographic and clinical data for research purposes.